• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Professional Introduction to 3-(Hydroxymethyl)piperidin-4-ol (CAS No. 682331-21-1)

3-(Hydroxymethyl)piperidin-4-ol, with the CAS number 682331-21-1, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This piperidine derivative features a hydroxymethyl group at the 3-position and a hydroxyl group at the 4-position, making it a versatile intermediate for the development of various pharmacologically active agents. The unique structural properties of this compound contribute to its utility in designing molecules with specific biological activities, particularly in the realm of drug discovery and medicinal chemistry.

The< b>Hydroxymethyl)piperidin-4-ol molecule is characterized by its chiral center, which allows for the synthesis of enantiomerically pure compounds. This property is particularly valuable in pharmaceutical applications where the stereochemistry of a molecule can significantly influence its efficacy and safety profiles. Recent advancements in asymmetric synthesis have enabled more efficient and scalable production methods for this compound, making it more accessible for industrial applications.

In recent years, there has been growing interest in the development of novel therapeutic agents targeting neurological disorders. The< b>piperidine scaffold is well-known for its role in central nervous system (CNS) drugs due to its ability to cross the blood-brain barrier and interact with various neurotransmitter receptors. The introduction of both hydroxymethyl and hydroxyl functional groups into the piperidine core enhances the compound's potential as a pharmacophore, allowing for greater flexibility in molecular design and optimization.

One of the most compelling aspects of 3-(Hydroxymethyl)piperidin-4-ol is its utility as a building block for more complex molecules. Researchers have leveraged this compound to synthesize derivatives with enhanced binding affinities and selectivity for specific biological targets. For instance, studies have demonstrated its use in creating novel antipsychotic and antidepressant agents, where the precise arrangement of functional groups can modulate receptor interactions and improve therapeutic outcomes.

The< b>hydroxymethyl group in particular offers multiple possibilities for further functionalization. It can undergo oxidation to form an aldehyde or carboxylic acid, or it can participate in etherification reactions to introduce additional structural complexity. These reactivities make 3-(Hydroxymethyl)piperidin-4-ol a valuable intermediate in multi-step synthetic routes, enabling chemists to construct intricate molecular architectures with high precision.

The pharmaceutical industry has also explored the use of 3-(Hydroxymethyl)piperidin-4-ol in the development of enzyme inhibitors. Piperidine derivatives are known to interact effectively with various enzymes, including those involved in metabolic pathways relevant to inflammation, pain, and cancer. By incorporating hydroxymethyl and hydroxyl groups, researchers can fine-tune the electronic and steric properties of the molecule to achieve optimal enzyme inhibition profiles.

In conclusion, 3-(Hydroxymethyl)piperidin-4-ol (CAS No. 682331-21-1) represents a promising compound with diverse applications in pharmaceutical research and drug development. Its unique structural features and reactivity make it an indispensable tool for medicinal chemists seeking to design innovative therapeutic agents. As our understanding of biological systems continues to evolve, compounds like this will play an increasingly critical role in addressing complex diseases and improving patient care.

• 252906-75-5(trans-3-(Hydroxymethyl)piperidin-4-ol)
• 252723-21-0(2-piperidin-3-ylpropan-2-ol)
• 33557-57-2(3-Methylpiperidin-4-ol)
• 36173-52-1(rac-(3S,4R)-3-methyl-4-piperidinol hydrochloride)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)